Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard C Becker

Showing results (211-220 of 436) with videos related to

Pageof 44
Sort By:
Chest|July 24, 2008
The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)James D Douketis, Peter B Berger, Andrew S Dunn, et al.
Chest|September 24, 2004
Antithrombotic therapy for coronary artery disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic TherapyRobert A Harrington, Richard C Becker, Michael Ezekowitz, et al.
Journal of Thrombosis and Thrombolysis|April 9, 2005
Vascular endothelial tissue factor pathway inhibitor kinetics in culture following exposure to DX-9065a--a selective and direct factor Xa inhibitorRichard C Becker, John H Alexander, Youfu Li, et al.
Thrombosis Research|May 11, 2005
Effect of the novel direct factor Xa inhibitor DX-9065a on thrombin generation and inhibition among patients with stable atherosclerotic coronary artery diseaseRichard C Becker, John H Alexander, Christopher Dyke, et al.
Journal of Thrombosis and Thrombolysis|October 12, 2021
Discussion of talks from the symposium: Factor X: From thrombokinase to oral anti-coagulants and beyondLeonard M Milstone, Craig Jackson, Richard C Becker, et al.
European Heart Journal|March 21, 2008
Impact of home warfarin use on treatment patterns and bleeding complications for patients with non-ST-segment elevation acute coronary syndromes: observations from the CRUSADE quality improvement initiativeTracy Y Wang, Anita Y Chen, Eric D Peterson, et al.
American Heart Journal|October 27, 2009
Design and rationale of the Evaluation of M118 IN pErcutaNeous Coronary intErvention (EMINENCE) trialChiara Melloni, Ian Fier, James Roach, et al.
Thrombosis and Haemostasis|September 9, 2016
Studies of the interaction of ticagrelor with the P2Y<sub>13</sub> receptor and with P2Y<sub>13</sub>-dependent pro-platelet formation by human megakaryocytesAnna Björquist, Christian A Di Buduo, Eti A Femia, et al.
Thrombosis Research|October 24, 2007
Platelet activation and its patient-specific consequencesSusan S Smyth, Dougald M Monroe, Waldemar E Wysokinski, et al.
Thrombosis Research|July 28, 2010
The effect of aspirin on endothelial progenitor cell biology: preliminary investigation of novel propertiesJunyang Lou, Thomas J Povsic, Jason D Allen, et al.
Pageof 44

Showing results (211-220 of 436) with videos related to

Sort By:
Pageof 44
Chest|July 24, 2008
The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)James D Douketis, Peter B Berger, Andrew S Dunn, et al.
Chest|September 24, 2004
Antithrombotic therapy for coronary artery disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic TherapyRobert A Harrington, Richard C Becker, Michael Ezekowitz, et al.
Journal of Thrombosis and Thrombolysis|April 9, 2005
Vascular endothelial tissue factor pathway inhibitor kinetics in culture following exposure to DX-9065a--a selective and direct factor Xa inhibitorRichard C Becker, John H Alexander, Youfu Li, et al.
Thrombosis Research|May 11, 2005
Effect of the novel direct factor Xa inhibitor DX-9065a on thrombin generation and inhibition among patients with stable atherosclerotic coronary artery diseaseRichard C Becker, John H Alexander, Christopher Dyke, et al.
Journal of Thrombosis and Thrombolysis|October 12, 2021
Discussion of talks from the symposium: Factor X: From thrombokinase to oral anti-coagulants and beyondLeonard M Milstone, Craig Jackson, Richard C Becker, et al.
European Heart Journal|March 21, 2008
Impact of home warfarin use on treatment patterns and bleeding complications for patients with non-ST-segment elevation acute coronary syndromes: observations from the CRUSADE quality improvement initiativeTracy Y Wang, Anita Y Chen, Eric D Peterson, et al.
American Heart Journal|October 27, 2009
Design and rationale of the Evaluation of M118 IN pErcutaNeous Coronary intErvention (EMINENCE) trialChiara Melloni, Ian Fier, James Roach, et al.
Thrombosis and Haemostasis|September 9, 2016
Studies of the interaction of ticagrelor with the P2Y<sub>13</sub> receptor and with P2Y<sub>13</sub>-dependent pro-platelet formation by human megakaryocytesAnna Björquist, Christian A Di Buduo, Eti A Femia, et al.
Thrombosis Research|October 24, 2007
Platelet activation and its patient-specific consequencesSusan S Smyth, Dougald M Monroe, Waldemar E Wysokinski, et al.
Thrombosis Research|July 28, 2010
The effect of aspirin on endothelial progenitor cell biology: preliminary investigation of novel propertiesJunyang Lou, Thomas J Povsic, Jason D Allen, et al.
Pageof 44